‘De-extinction’ startup Colossal Biosciences makes its first acquisition: a company that clones pets

Scooping up ViaGen Pets and Equine ostensibly adds more genetic firepower to Colossal’s arsenal. Terms of the acquisition were not disclosed. The cloning industry is contracting—ironically, perhaps.